Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients

Completed

• Conditions: Breast Cancer

• Registration Number: NCT00727883
• Lead Sponsor: AstraZeneca

Brief Summary

Retrospective observational trial on reasons for withdraw of Adjuvant Tamoxifen in Breast Cancer patients

Detailed Description

Not available

Study Timeline

• Study Start: 2007-07
• Primary Completion: 2008-05
• Study Completion: 2008-05
• Study First Submitted: 2008-07-31
• Study First Submitted QC: 2008-08-01
• Study First Posted: 2008-08-04
• Status Verified: 2010-12
• Last Update Submitted: 2010-12-09
• Last Update Posted: 2010-12-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 190

Inclusion Criteria

• Breast Ca Patients with surgery and withdraw of adjuvant treatment with Tamoxifen for Tam related AEs
• Documented reasons for treatment withdrawal

Read More

Exclusion Criteria

• enrollment in other studies
• treatment withdraw for other causes than Tam related AEs

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
incidence of withdraw from adjuvant Tamoxifen due to Tam related AEs	January 2003-December 2004

Secondary Outcome Measures

Name	Time	Method
Types of TAM related AE	January 2003-December 2004